← FDA Drug Approvals (Drugs@FDA)
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANDA REPOSITORY · Approved 2022-06-27
Drug application
- FDA Application #
ANDA214201- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
- Generic name
- DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
- Active ingredients
- DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- Dosage form
- SOLUTION
- Route
- ORAL, RECTAL
- Marketing status
- Prescription
- Sponsor
- ANDA REPOSITORY
- Manufacturer
- Guardian Drug Company
- First approval
- 2022-06-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown